Future directions and treatment strategies for head and neck squamous cell carcinomas
Translational Research, The Journal of Laboratory and Clinical Medicine, 08/21/2012
Wise–Draper TM et al. – The findings suggests that tumors with high DEK protein expression may be correlated with poor clinical response to clastogenic therapies. Targeting molecules such as DEK in combination with new and/or conventional therapies, holds promise for novel future therapeutics for head and neck cancer.